Russia and Kazakhstan Will Dominate Planned Upstream Projects in the Former Soviet Union to 2025

Russia is responsible for 25 key crude and natural gas projects expected to commence operations by 2025, dominating the Former Soviet Union’s (FSU) oil and gas production. The two other key planned projects in the FSU region are in Kazakhstan, led by the colossal Kashagan crude oil project, which is thought to be the world’s largest discovery in the last 30 years. Russia will account for most of the planned oil and gas production in the FSU, with Gazprom contributing the highest oil and gas production in the region by 2025.

GlobalData’s Production and Capital Expenditure Outlook for Key Planned Upstream Projects in Countries of the Former Soviet Union report provides analysis on oil and gas production by key countries and companies in the Former Soviet Union (FSU) region from 2016 to 2025. It includes detailed information on the number of planned projects and their start dates by key countries and companies in the FSU region, as well as information on their capital expenditures.

Single User Price: $1,500

Global Switchgear Market to hit $84 Billion by 2020

While the potential growth of the switchgear space will be a boon to manufacturers of the product worldwide, the market will be rocked somewhat by upcoming Asian manufacturers posing challenges to established ones. In the Chinese high-voltage switchgear market, established international players face tough competition from the local manufacturers, which together account for almost 85% of the market. Even in India, domestic manufacturers hold a significant share of the market in the medium- and low-voltage segments. The presence of so many manufacturers in the arena, particularly in the Chinese and Indian markets, will induce intense competition and huge pricing pressures.

GlobalData’s Switchgear Market for Power Industry, Update 2015 – Global Market Size, Equipment Market Share and Key Country Analysis to 2020 report provides analysis of the global switchgear market, with annualized market data from 2006 and forecast to 2020, with a particular focus on the US, Canada, China, India, the UK, Italy and Saudi Arabia.

Single User Price: $3,995

Private Companies Dominate the Acrylonitrile sector in China

Acrylonitrile is a high volume commodity. The Chinese Acrylonitrile plant capacity is expected to increase from 1.698 MMTPA in 2014 to 2.938 MMTPA in 2019, at a CAGR of 11.6%. Private companies dominate the Acrylonitrile sector in China. The major companies in the region are China National Petroleum Corporation, China Petrochemical Corporation, China Wanda Group, BP p.l.c. and China Petroleum & Chemical Corporation. Together these companies accounted for 93.3% of the Acrylonitrile capacity in China in 2014.

GlobalData’s report, Acrylonitrile Industry Outlook in China to 2019 – Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants”, provides up to date in-depth information on China’s Acrylonitrile industry. The report covers China’s Acrylonitrile plants and presents installed capacity by production process and technology. The report offers historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data, and company shares of the country’s leading Acrylonitrile producers.

Single User Price: $1,000

Laparoscopy Will Drive Hernia Repair Market to $2.5 billion by 2021

The global market for hernia repair will expand from $1.8 billion in 2014 to reach $2.4 billion by 2021, representing a moderate compound annual growth rate of 4%. Studies have shown that laparoscopic repair is more expensive than open repair by around $500, which may negatively affect adoption of the technique. Laparoscopy is very technically demanding, and few surgeons are yet completely trained and effective in performing the procedure. However, the benefits of the technique, such as lower incidences of chronic pain and recurrence, and shorter recovery times, mean there will still be strong demand from patients during the forecast period.

GlobalData’s MediPoint: Hernia Repair – Global Analysis and Market Forecasts report provides analysis of the hernia repair space across the 10 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India, including market data from 2014 and forecast until 2021.

Single User Price: $6,495

Private Companies to Dominate the Polypropylene Industry in Saudi Arabia

Saudi Arabia Polypropylene plant capacity is expected to increase from 5.990 MMTPA in 2014 to 6.040 MMTPA in 2019, at a CAGR of 0.2%. Private companies dominate the Polypropylene sector in Saudi Arabia. The major companies in the region are Advanced Petrochemical Company, National Industrialization Company, Project Management & Development CO. LTD., Saudi Basic Industries Corporation and Sahara Petrochemicals Company. Together these companies accounted for 56.8% of the Polypropylene capacity in Saudi Arabia in 2014.

GlobalData’s report, “Polypropylene Industry Outlook in Saudi Arabia to 2019 – Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants”, provides up to date in-depth information on Saudi Arabia’s Polypropylene industry, including major market trends, and plants installed capacity by production process and technology.

Published: Dec’15 – Single user price: $1,000

Average Capex Spending is estimated to Decrease by 2020

The global upstream production is expected to increase at an average rate of 1% over the next four years to 59,210 mmboe by 2020. The global planned projects are expected to total 306 between 2016 and 2020 with top regions for development being Europe (72), South America (63), and Africa (57). The average capex spending is estimated to decrease over the next four years from about US$190,976 million in 2016 to US$94,125 million in 2020, correlating to downward trend in commodity pricing, reflected in reduced development costs such as rig leasing.

GlobalData’s latest report, “Monthly Global Upstream Review – Capital Expenditure Forecast Continues Decline provides a key economic metrics for the global oil and gas industry by key regions and companies. It includes global oil and gas production forecast and liquids and natural gas production forecast by region for the period 2016 to 2020.

Published: Feb’16 – Single user price: $1,500

China Remains Largest Producer of Solar PV Modules

Globally, the Asia-Pacific region has the maximum share of installed capacity, at around 61%, with China’s installed capacity about 18.43 GW in 2015. China held about a 23% share of the world’s c-Si installed capacity, and a 2.46% share of the thin-film installed capacity in 2015. Being a manufacturing hub, with favorable conditions for the manufacturing industry, China has maintained its position in the market for the eighth consecutive year. US held the second largest share in the solar PV market replacing Japan to third position, with installed capacity of 8.2 GW and 8 GW respectively, in 2015. Of the world’s c-Si capacity share, Japan held 25% and, in 2014, its thin-film production share was 26.36% – second to Malaysia, which contributed around 40%.

GlobalData’s “Solar PV Module Market, Update 2015 – Market Size, Average Price, Market Share and Key Country Analysis to 2020 report provides detailed information on the current solar PV module market, focusing on key countries as well as the global scenario. The report analyses annual module installation trends, module production volume and capacity, module production share, average module price and market size for global and key countries. Key countries include China, India, the US, Germany, Japan, Italy, Canada, UK, France and Australia.

Published: Jan’16 – Single user price: $3,995

Indonesia’s Pharmaceutical Market Will Continue Rapid Growth to $12.6 Billion by 2020

The pharmaceutical market in Indonesia more than doubled from just under $3 billion in 2008 to reach approximately $7 billion in 2015 and is anticipated to increase further to $12.6 billion by 2020, driven primarily by the Indonesian government’s economic and healthcare initiatives. Indonesia’s pharmaceutical sector will be boosted by the establishment of a universal healthcare scheme, known as the Jaminan Kesehatan Nasional. This was launched in January 2014 with the aim of providing health insurance to 250 million Indonesian citizens by 2019, which would make it the world’s largest social health insurance. New economic policy packages, the high prevalence of infectious diseases, widespread generic drug supply, increasing affordability of healthcare products and the large over-the-counter medicines market will also help to drive growth in Indonesia’s pharmaceutical sector.

GlobalData’s “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indonesia report provides information on Indonesia’s healthcare, regulatory, and reimbursement landscape, with annualized market data on the pharmaceutical and medical devices sectors from 2014 and forecast to 2020. It includes detailed analysis of the political and economic environment, covering economic indicators, demographics, and healthcare infrastructure and expenditure in Indonesia.

Published: Feb’16 – Single user price: $1,995

Deal Values in Pharmaceutical & Healthcare Industry Increased in Q4 2015

The pharmaceutical and healthcare industry reported an increase in deal value in Q4 2015 with USD237.7 billion compared to USD201.3 billion in Q4 2014. However, the number of deals decreased in Q4 2015 with 1,013, as compared to 1,143 in Q4 2014. On a quarter-on-quarter basis, the number of deals decreased and deal values increased in Q4 2015, when compared to 1,053 deals worth USD145.7 billion in Q3 2015. Licensing agreements recorded an increase in upfront payments and milestone payments in Q4 2015. A total of USD867.6m and USD10.4 billion were reported as upfront and milestone payments in Q4 2015, compared to USD729.3m and USD6.5 billion, respectively in Q4 2014.

GlobalData’s Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2015 report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides detailed information on partnerships, licensing agreements, M&As, equity/debt offerings, private equity and venture financing transactions registered in the pharmaceutical and healthcare industry in Q4 2015.

Published: Feb’16 – Single user price: $1,500

Deal Values Decreased in the Power Industry in Q4 2015

Asset transactions, including project financing, self-funded, tax equity, lease and bond financing, and bridge loans for acquisition of assets, registered a marginal decrease in the number of deals and an increase in deal value in Q4 2015. The market registered 684 deals worth US$117.1 billion in Q4 2015, as compared to 756 deals worth US$176.9 billion in Q3 2015. The solar segment reported highest number of asset acquisitions with 51 deals worth US$2.2 billion in Q4 2015, followed by wind energy with 45 deals worth US$2.8 billion, fossil fuels with 15 deals worth US$4.2 billion and hydro with 13 deals worth US$1.4 billion during the same period.

GlobalData’s “Power Quarterly Deals Analysis: M&A and Investment Trends – Q4 2015” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financing in the power industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the power industry in Q4 2015. The report discloses detailed comparative data on the number of deals and their value in the past five quarters, categorized into deal types, segments, and geographies. The report provides information on the top private equity, venture capital and advisory firms in the power industry.

Single User Price: $1,500